TG Therapeutics, Inc. Announces Preclinical Data Presentation on the Company’s Anti-PD-L1 Monoclonal Antibody at the American ...
NEW YORK, April 04, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced the first presentation of preclinical data on the Company’s novel fully human anti-PD-L1 monoclonal antibody at the American Association for Cancer Research ( …